ATRC Insider Trading
AtriCure, Inc. | Surgical & Medical Instruments & Apparatus
Comprehensive Trading Performance Summary
The investment history of corporate insiders at AtriCure, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Surgical & Medical Instruments & Apparatus sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2025-11-27 00:43 | 2025-11-24 | WEHRWEIN SVEN | Director | OPT+S | $37.66 | 10,000 | $376,578 | 34,374 | 0.0% |
| 2025-11-27 00:41 | 2025-11-26 | Noznesky Justin J | Officer - Chief Mktg & Strategy Officer | SELL | $37.29 | 5,166 | $192,640 | 78,798 | -6.2% |
| 2025-11-25 17:01 | 2025-11-21 | Yuen Maggie | Director | SELL | $35.72 | 3,000 | $107,160 | 11,371 | -20.9% |
| 2025-09-16 15:45 | 2025-09-12 | Noznesky Justin J | Officer - Chief Mktg & Strategy Officer | SELL | $36.30 | 3,000 | $108,900 | 83,964 | -3.4% |
| 2025-08-26 15:27 | 2025-08-22 | WEHRWEIN SVEN | Director | OPT+S | $37.00 | 5,000 | $185,000 | 34,374 | 0.0% |
| 2025-08-21 16:04 | 2025-08-19 | WEHRWEIN SVEN | Director | OPT+S | $36.00 | 5,000 | $180,000 | 34,374 | 0.0% |
| 2025-08-08 16:12 | 2025-08-06 | GROVES REGINA E | Director | SELL | $36.82 | 2,452 | $90,283 | 33,715 | -6.8% |
| 2025-08-07 15:45 | 2025-08-05 | Doraiswamy Vinayak | Officer - Chief Scientific Officer | SELL | $36.58 | 2,500 | $91,450 | 71,872 | -3.4% |
| 2025-05-30 23:21 | 2025-05-28 | Doraiswamy Vinayak | Officer - Chief Scientific Officer | SELL | $33.44 | 2,500 | $83,600 | 73,550 | -3.3% |
| 2025-03-07 16:21 | 2025-03-05 | Prange Karen | Director | SELL | $38.12 | 6,100 | $232,532 | 17,828 | -25.5% |
| 2024-08-19 15:46 | 2024-08-15 | Yuen Maggie | Director | SELL | $24.07 | 3,500 | $84,245 | 8,970 | -28.1% |
| 2024-05-31 23:12 | 2024-05-30 | Privitera Salvatore | Officer - Chief Technical Officer | BUY | $22.25 | 5,000 | $111,250 | 103,290 | +5.1% |
| 2024-05-03 15:51 | 2024-05-01 | Noznesky Justin J | Officer - Chief Mktg & Strategy Officer | SELL | $24.09 | 1,500 | $36,135 | 71,284 | -2.1% |
| 2024-04-03 15:41 | 2024-04-01 | Noznesky Justin J | Officer - Chief Mktg & Strategy Officer | SELL | $30.39 | 1,500 | $45,585 | 72,784 | -2.0% |
| 2024-03-20 15:41 | 2024-03-18 | Dahlquist Karl S. | Officer - Chief Legal Officer | SELL | $32.16 | 1,885 | $60,622 | 50,954 | -3.6% |
| 2024-03-14 15:55 | 2024-03-12 | Noznesky Justin J | Officer - Chief Mktg & Strategy Officer | SELL | $36.72 | 1,500 | $55,080 | 74,284 | -2.0% |
| 2024-03-07 15:28 | 2024-03-05 | Dahlquist Karl S. | Officer - Chief Legal Officer | SELL | $37.36 | 8,231 | $307,510 | 52,839 | -13.5% |
| 2023-11-03 15:40 | 2023-11-01 | Dahlquist Karl S. | Officer - Chief Legal Officer | SELL | $34.43 | 1,248 | $42,969 | 30,789 | -3.9% |
| 2023-07-28 15:39 | 2023-07-26 | Dahlquist Karl S. | Officer - Chief Legal Officer | SELL | $57.09 | 3,417 | $195,077 | 32,037 | -9.6% |
| 2023-06-12 15:59 | 2023-06-08 | Prange Karen | Director | SELL | $47.89 | 713 | $34,146 | 16,140 | -4.2% |
| 2023-06-07 15:43 | 2023-06-06 | Dahlquist Karl S. | Officer - Chief Legal Officer | SELL | $47.03 | 1,422 | $66,877 | 34,897 | -3.9% |
| 2023-05-30 23:05 | 2023-05-26 | Yuen Maggie | Director | SELL | $47.04 | 4,313 | $202,884 | 4,682 | -47.9% |
| 2023-05-03 23:03 | 2023-05-01 | Dahlquist Karl S. | Officer - Chief Legal Officer | SELL | $44.83 | 4,417 | $198,014 | 36,319 | -10.8% |
| 2022-09-19 23:49 | 2022-09-15 | Doraiswamy Vinayak | Officer - Chief Scientific Officer | SELL | $45.99 | 4,983 | $229,168 | 19,406 | -20.4% |
| 2022-05-17 15:41 | 2022-05-13 | Austin Tonya | Officer - Chief Human Resources Officer | SELL | $42.69 | 3,203 | $136,736 | 17,621 | -15.4% |
| 2022-04-12 14:53 | 2022-04-08 | Austin Tonya | Officer - Chief Human Resources Officer | SELL | $61.59 | 282 | $17,368 | 20,824 | -1.3% |
| 2022-03-07 15:55 | 2022-03-04 | Austin Tonya | Officer - Chief Human Resources Officer | SELL | $67.66 | 1,409 | $95,333 | 21,106 | -6.3% |
| 2022-03-04 15:26 | 2022-03-02 | Austin Tonya | Officer - Chief Human Resources Officer | SELL | $70.04 | 4,885 | $342,132 | 22,515 | -17.8% |
| 2022-02-15 16:01 | 2022-02-11 | Austin Tonya | Officer - Chief Human Resources Officer | SELL | $67.97 | 2,490 | $169,245 | 20,340 | -10.9% |
| 2022-01-18 17:05 | 2022-01-14 | Austin Tonya | Officer - Chief Human Resources Officer | SELL | $66.11 | 2,719 | $179,753 | 22,830 | -10.6% |
| 2021-12-14 16:32 | 2021-12-10 | Austin Tonya | Officer - Chief Human Resources Officer | SELL | $70.88 | 1,528 | $108,305 | 25,408 | -5.7% |
| 2021-11-17 00:36 | 2021-11-12 | Austin Tonya | Officer - Chief Human Resources Officer | SELL | $78.55 | 2,732 | $214,599 | 26,936 | -9.2% |
| 2021-11-08 16:15 | 2021-11-04 | Wirick Angela L | Officer - Chief Financial Officer | SELL | $85.00 | 2,604 | $221,340 | 70,146 | -3.6% |
| 2021-11-08 16:12 | 2021-11-04 | Collar Mark A | Director | SELL | $80.91 | 4,000 | $323,640 | 77,307 | -4.9% |
| 2021-10-29 23:30 | 2021-04-30 | GROVES REGINA E | Director | BUY | $76.68 | 34 | $2,607 | 16,228 | +0.2% |
| 2021-10-12 15:14 | 2021-10-08 | Austin Tonya | Officer - Chief Human Resources Officer | SELL | $71.80 | 665 | $47,747 | 29,668 | -2.2% |
| 2021-09-17 23:45 | 2021-09-15 | GROVES REGINA E | Director | SELL | $74.73 | 3,156 | $235,848 | 16,194 | -16.3% |
| 2021-09-15 23:38 | 2021-09-13 | Seith Douglas J | Officer - Chief Operating Officer | SELL | $75.54 | 21,444 | $1,619,880 | 64,711 | -24.9% |
| 2021-09-14 15:16 | 2021-09-10 | Austin Tonya | Officer - Chief Human Resources Officer | SELL | $77.18 | 1,227 | $94,700 | 30,333 | -3.9% |
| 2021-08-17 15:29 | 2021-08-13 | Austin Tonya | Officer - Chief Human Resources Officer | SELL | $73.10 | 3,232 | $236,259 | 31,560 | -9.3% |
| 2021-08-12 00:17 | 2021-08-09 | Seith Douglas J | Officer - Chief Operating Officer | SELL | $80.79 | 7,065 | $570,781 | 86,155 | -7.6% |
| 2021-08-10 15:06 | 2021-08-06 | Wirick Angela L | Officer - Chief Financial Officer | SELL | $80.21 | 5,939 | $476,367 | 77,941 | -7.1% |
| 2021-08-03 15:11 | 2021-07-30 | Privitera Salvatore | Officer - Chief Technical Officer | SELL | $85.00 | 8,808 | $748,680 | 52,419 | -14.4% |
| 2021-07-30 15:41 | 2021-07-28 | Privitera Salvatore | Officer - Chief Technical Officer | SELL | $82.50 | 8,000 | $660,000 | 61,227 | -11.6% |
| 2021-07-22 23:34 | 2021-07-20 | Privitera Salvatore | Officer - Chief Technical Officer | SELL | $80.00 | 2,000 | $160,000 | 69,227 | -2.8% |
| 2021-07-20 14:59 | 2021-07-16 | Austin Tonya | Officer - Chief Human Resources Officer | SELL | $78.03 | 493 | $38,469 | 34,792 | -1.4% |
| 2021-07-14 23:37 | 2021-07-12 | Doraiswamy Vinayak | Officer - Chief Scientific Officer | SELL | $83.12 | 7,672 | $637,697 | 16,875 | -31.3% |
| 2021-07-06 14:54 | 2021-07-01 | Collar Mark A | Director | SELL | $79.61 | 3,000 | $238,830 | 81,307 | -3.6% |
| 2021-07-02 23:03 | 2021-07-01 | Dahlquist Karl S. | Officer - Chief Legal Officer | SELL | $79.53 | 336 | $26,722 | 15,801 | -2.1% |
| 2021-06-29 15:10 | 2021-06-25 | Noznesky Justin J | Officer - Chief Mktg & Strategy Officer | SELL | $80.00 | 4,119 | $329,520 | 30,689 | -11.8% |
How to Interpret $ATRC Trades
Not every insider transaction in AtriCure, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $ATRC shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for ATRC
Insider activity data for AtriCure, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $ATRC, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.